Persistent Infections: Understanding Long-Lasting Microbial Infections

A persistent infection is one where the pathogen evades clearance and remains in the host for months to life, often with periods of latency and reactivation.

Mechanisms of Persistence

  • Immune evasion: Antigenic variation (HIV, influenza), latency programs (herpesviruses), intracellular niche (TB, Salmonella), immunosuppression (HIV, measles).
  • Biofilms: Structured communities resistant to antibiotics/phagocytes (Pseudomonas, Staph, Candida).
  • Host factors: Immunodeficiency, genetic susceptibility, anatomic sanctuaries (CNS, testes, eye).

Major Persistent Infections

Consequences

  • Chronic inflammation → tissue damage, fibrosis, cancer.
  • Immune exhaustion, immunosenescence.
  • Transmission risk (sexual, vertical, blood).

Treatment Challenges

  • Sterilizing cure rare (HCV with DAAs – exception).
  • Goals: suppression (HIV, HBV), latency control (TB, herpes), eradication (H. pylori), or management.
  • Antimicrobial resistance complicates long-term therapy.

Understanding persistence mechanisms drives novel curative strategies (shock-and-kill, gene editing, immune modulation).

Infectious Diseases - Related Articles

Health Sciences © https://www.222health.com

PathogenTypePersistence MechanismKey Features
HIVRetrovirusIntegration into host genome; latent reservoirCD4+ depletion → AIDS; lifelong ART
Hepatitis B/CDNA/RNA viruscccDNA (HBV) / immune exhaustion (HCV)Chronic hepatitis → cirrhosis, HCC
Mycobacterium tuberculosisBacteriumGranuloma latency; reactivation if immunosuppressedLatent TB infection (LTBI) in 1/4 world
Malaria (P. vivax/ovale)ProtozoanHypnozoites in liverRelapsing malaria; primaquine/tafenoquine
Herpes simplex (HSV-1/2)DNA virusNeuronal latency (trigeminal/sacral ganglia)Recurrent mucocutaneous lesions
EBVHerpesvirusB-cell latency; periodic reactivationMono; linked to lymphomas, NPC
CMVHerpesvirusMyeloid latencySevere in immunocompromised; congenital
HPVDNA virusEpisomal persistence in basal epitheliumWarts; high-risk → cervical/oral/anal CA